Onabotulinumtoxina

CHEMBL1201574 Phase 4 Approuvé Unknown

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

— g/mol

LogP

—

Phase

4

A purified neurotoxin derived from Clostridium botulinum, injected into muscles or glands to temporarily paralyze them and treat a wide range of conditions including chronic migraine, overactive bladder, cervical dystonia, excessive sweating, and cosmetic wrinkles. It works by blocking the release of acetylcholine at nerve–muscle junctions.

Aires thérapeutiques

Infectious Disease Pancreatic Cancer Benign Prostatic Hyperplasia Respiratory Disease Pain Management Rheumatoid Arthritis Chronic Obstructive Pulmonary Disease Alzheimer's Disease Parkinson's Disease Migraine Generalized Anxiety Disorder Gastroesophageal Reflux Disease Inflammatory Bowel Disease Psoriasis Obstetrics & Gynecology Systemic Lupus Erythematosus Multiple Sclerosis Chronic Kidney Disease Non-Alcoholic Fatty Liver Disease Stroke Obesity Transplant Medicine Major Depressive Disorder Breast Cancer Atopic Dermatitis Chronic Pain Atrial Fibrillation Cardiovascular Disease Prostate Cancer Colorectal Cancer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

A purified neurotoxin derived from Clostridium botulinum, injected into muscles or glands to temporarily paralyze them and treat a wide range of conditions including chronic migraine, overactive bladder, cervical dystonia, excessive sweating, and cosmetic wrinkles. It works by blocking the release of acetylcholine at nerve–muscle junctions.

Yes, Onabotulinumtoxina is an approved drug. It has reached clinical phase 4. It is classified as a Unknown.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201574. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Onabotulinumtoxina sur PillFYI

Données Clés

Synonymes: 2

Liens externes

ChEMBL CHEMBL1201574

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.